DrugPatentWatch Database Preview
Scilex Pharms Inc Company Profile
What is the competitive landscape for SCILEX PHARMS INC, and what generic alternatives to SCILEX PHARMS INC drugs are available?
SCILEX PHARMS INC has one approved drug.
There are three US patents protecting SCILEX PHARMS INC drugs.
There are ten patent family members on SCILEX PHARMS INC drugs in seven countries.
Summary for Scilex Pharms Inc
| International Patents: | 10 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Scilex Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms Inc | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,925,264 | Start Trial | Y | Start Trial | |||
| Scilex Pharms Inc | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | 9,283,174 | Start Trial | Y | Start Trial | |||
| Scilex Pharms Inc | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scilex Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | WO2012153396 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2012153396 | Start Trial |
| Canada | 2835595 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
